Back to search

Article

Atorvastatin Protects Against Carfilzomib-Induced Deleterious Transcriptional Changes in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

2025-12-23

Abstract excerpt

The mechanisms underlying carfilzomib (CFZ)-induced cardiotoxicity remain incompletely elucidated. In this study, we used human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) to char-acterize the transcriptional impact of CFZ and to evaluate whether atorvastatin could prevent these dele-terious transcriptional changes. hiPSC-CMs were treated with 1 µM CFZ, CFZ + atorvastatin, atorvastatin, or veh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9d3ac945-4a93-5483-9dec-9e58acf0b317
DOI
10.20944/preprints202512.2070.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Atorvastatin Protects Against Carfilzomib-Induced Deleterious Transcriptional Changes in Human Induced Pluripotent Stem Cell-Derived CardiomyocytesDOI 10.20944/preprints202512.2070.v1
Select a neighboring publication to make it the new centre.